You are here
Home- Overview
- Agenda
- Speakers
- Sponsors
- Location
- Contact
- 8:30 AM to 4:00 PM
- MaRS Discovery District
The Drug Development Program – Phase 1 (DDP1) at Princess Margaret Cancer Centre is excited to announce their first symposium on Anticancer Developmental Therapeutics. It will take place on Friday, November 1, 2024 in the MaRS Discovery District Auditorium, 101 College Street, Toronto, Canada. The one-day symposium will have talks focused on immunotherapies and cancer therapeutics.
*****In-person registration now closed.*****
Only VIRTUAL registration remains open.
Online registration is mandatory for all attendees. The event will also be broadcast virtually and a livestream link will be sent to remote attendees prior to the event.
Anticancer Developmental Therapeutics Symposium
Friday, November 1st, 2024 | MaRS Discovery District and Online (Hybrid Event)
Keith Stewart, MD, Vice President Cancer, and Director of the Princess Margaret Cancer Centre, University Health Network
Session Chair: Dr. Anna Spreafico, MD, PhD, Princess Margaret Cancer Centre, Toronto, ON
Speaker: Anthony Tolcher, MD, NEXT Oncology, San Antonio, TX
Speaker: Mercedes Herrera, MD, MSc, Princess Margaret Cancer Centre, Toronto, ON
Speaker: Irene Braña, MD, Vall d'Hebron Institute of Oncology, Barcelona, Spain
All morning session speakers
Speaker: Mona Shafey, MD, Foothills Medical Centre, Calgary, AB
Speaker: Ramy Saleh, MD, MSc, McGill University Helath Centre, Montreal, QC
Session Chair: Abdulazeez Salawu, MMBS, MSc, MRCP, PhD, Princess Margaret Cancer Centre, Toronto, ON
Speaker: Lillian Siu, MD, Princess Margaret Cancer Centre, Toronto, ON
Speaker: Dina Lansey, MSN, Johns Hopkins Medicine, Baltimore, MD
All afternoon session speakers
Speaker: Scott Strum, MD, MSc, Princess Margaret Cancer Centre, Toronto, ON
Speaker: Timothy Yap, MD, PhD, MD Anderson Cancer Center, Houston, TX
All afternoon session speakers
In Person Location:
MaRS Discovery District Auditorium
101 College Street
Toronto, ON
M5G 1L7
DDP1 Symposium Team
Drug Development Program - Phase 1
Princess Margaret Cancer Centre
700 University Avenue, 2N-216
Toronto, ON M5G 1Z5
Email: dctsymposiums@uhn.ca